Status: Not yet recruiting
Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study
Prospective, Multi-Center, Randomized, shame-Controlled, Uptake clinical trial to evaluate the efficacy and safety of the six-channel radio-frequency（RF) renal denervation system-comprising the six-channel RF generator (specification model: 25D1G, software release version: SRG-V1) and the disposable ultra-guiding RF denervation catheter (specification model: 25C6W127F115T)-for renal denervation in patients with grade I hypertension and without taking antihypertensive medicines.
Participants needed: 20
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Ruijin HospitalUpdated: Jun 24, 2026
Eligibility criteria
Male or female, aged 18 to 65 years inclusive [+3]
Pregnant or breastfeeding, or planning pregnancy during the study. [+16]